|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.612
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.525
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.499
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.465
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.432
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.419
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.351
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.305
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.304
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.303
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.237
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.236
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.234
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.222
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.205
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.177
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.166
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.159
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.159
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.156
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.154
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.150
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.148
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.147
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.135
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.135
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.124
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.116
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.115
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.114
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.110
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.108
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.102
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.099
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.092
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.090
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.088
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.088
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.087
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.086
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.084
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.083
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.083
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.079
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.076
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.074
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.074
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.074
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.073
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.073
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.070
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.070
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.068
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.068
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.064
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.063
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.063
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.063
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.062
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.062
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.061
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.061
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.061
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.058
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.057
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.056
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.056
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.056
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.055
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.055
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.054
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.054
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.054
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.054
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.054
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.053
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.053
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.052
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.052
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.052
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.051
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.051
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.050
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.050
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.050
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.050
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.050
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.050
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.049
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.049
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.048
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.048
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.048
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.047
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.047
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.046
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.046
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.045
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.045
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.045
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.045
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.045
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.045
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.045
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.045
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.045
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.044
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.044
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.044
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.043
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.043
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.042
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.042
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.042
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.042
|
|
|
|
contact inhibition
|
GO:0060242 |
3 |
0.041
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.041
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.039
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.039
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.039
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.038
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.038
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.038
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.038
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.037
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.037
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.037
|
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.037
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.036
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.036
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.035
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.035
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.035
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.034
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.034
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.034
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.033
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.033
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.033
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.032
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.031
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.031
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.031
|
|
|
|
neurotransmitter catabolic process
|
GO:0042135 |
3 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.030
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.030
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.030
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.030
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.029
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.029
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.029
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.029
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.029
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.029
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.029
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.029
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.029
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.028
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.028
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.028
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.028
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.028
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.028
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.028
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.028
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.027
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.027
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.027
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.027
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.027
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.027
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.027
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.027
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.026
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.026
|
|
|
|
dendritic cell dendrite assembly
|
GO:0097026 |
2 |
0.026
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.026
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.025
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.025
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.025
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.025
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.025
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.025
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.025
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.025
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.025
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.025
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.025
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.025
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.024
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.024
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.024
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.024
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.024
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.024
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.024
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.024
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.023
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.023
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.023
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.023
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.023
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.023
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.023
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.022
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.022
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.022
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.022
|
|
|
|
positive regulation of cd4 positive alpha beta t cell proliferation
|
GO:2000563 |
1 |
0.022
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.022
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.021
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.021
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.021
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.021
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.021
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.021
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.020
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.020
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.020
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.020
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.020
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.020
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.020
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.020
|
|
|
|
hypotonic response
|
GO:0006971 |
3 |
0.020
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.019
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.019
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.019
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.019
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.019
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.019
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.019
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.019
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.019
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.018
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.018
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.018
|
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.018
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.018
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.018
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.018
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.017
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.017
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.017
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.017
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.017
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.017
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.017
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.017
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.017
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.017
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.017
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.017
|
|
|
|
regulation of cardiac muscle hypertrophy
|
GO:0010611 |
13 |
0.017
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.017
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.016
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.016
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.016
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
3 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.016
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.016
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.016
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.016
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.016
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.016
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.016
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.016
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.016
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.016
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.016
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.016
|
|
|
|
positive regulation of dendritic cell chemotaxis
|
GO:2000510 |
1 |
0.016
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.015
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.015
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.015
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.015
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.015
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.015
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.015
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.015
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.015
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.015
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.015
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.015
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.014
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.014
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.014
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.014
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.014
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.014
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.014
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.014
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.014
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.014
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.014
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.014
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.014
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.014
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.014
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.014
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.014
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.014
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.014
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.014
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.014
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.014
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.014
|
|
|
|
positive regulation of glycogen metabolic process
|
GO:0070875 |
8 |
0.014
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
22 |
0.013
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.013
|
|
|
|
metanephric glomerular mesangial cell differentiation
|
GO:0072254 |
1 |
0.013
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.013
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.013
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.013
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.013
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.013
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.013
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.013
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.013
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.013
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.013
|
|
|
|
regulation of b cell chemotaxis
|
GO:2000537 |
2 |
0.013
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.013
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.013
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.013
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.013
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.012
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.012
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.012
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.012
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.012
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.012
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.012
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.012
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.012
|
|
|
|
regulation of dendritic cell dendrite assembly
|
GO:2000547 |
2 |
0.012
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.012
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.012
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.012
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.012
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
21 |
0.012
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.012
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.012
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.012
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.012
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.012
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.011
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.011
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.011
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.011
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.011
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.011
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.011
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.011
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.011
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.011
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.011
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.011
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.011
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.011
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.011
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.011
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.011
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.011
|
|